Antitumor mechanisms of attenuated Salmonella typhimurium containing the gene for human interleukin-2: A novel antitumor agent?
- 28 February 1997
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 32 (2), 301-306
- https://doi.org/10.1016/s0022-3468(97)90198-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- AttenuatedSalmonella typhimuriumContaining Interleukin-2 Decreases MC-38 Hepatic Metastases: A Novel Anti-tumor AgentCancer Biotherapy & Radiopharmaceuticals, 1996
- Surgical options in the treatment of hepatic metastasis from colorectal cancerCurrent Problems in Surgery, 1995
- Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 geneCancer Immunology, Immunotherapy, 1995
- Effects of Route and Formulation on Clinical Pharmacokinetics of Interleukin-2Clinical Pharmacokinetics, 1994
- Interleukin-2Drugs, 1993
- Lowest dose interleukin-2 immunotherapy [see comments]Blood, 1993
- Heterogeneity of rat liver and spleen macrophages in gadolinium chloride–induced elimination and repopulationJournal of Leukocyte Biology, 1992
- Clinical Toxicity of Interleukin-2Drug Safety, 1992
- A ‘safe-site’ for Salmonella typhimurium is within splenic cells during the early phase of infection in miceMicrobial Pathogenesis, 1991
- Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.The Journal of Experimental Medicine, 1991